Variability in placebo analgesia and the role of fear of pain—an ERP study
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Fear of pain (FOP) and its effect on placebo analgesia was investigated. It was hypothesized that FOP should interfere with placebo-mediated pain inhibition and result in weaker placebo responding in pain intensity, pain unpleasantness, stress, and event-related potentials to contact heat pain. Thirty-three subjects participated in a balanced 2 condition (natural history, placebo)×3 test (pretest, posttest 1, posttest 2) within-subject design, tested on 2 separate days. FOP was measured by the Fear of Pain Questionnaire and subjective stress by the Short Adjective Check List. Placebo effects were found on reported pain unpleasantness and N2 and P2 amplitudes. FOP was related to reduced placebo responding in pain unpleasantness, but this was only evident for the subjects who received the placebo condition on day 1. Subjects who received the placebo condition on day 1 experienced more pretest stress than those who received the placebo condition on day 2 (ie, reversed condition order), and this explained the interaction effect on placebo responding. FOP was related to reduced placebo responding on P2 amplitude, whereas placebo responding on N2 amplitude was unaffected by FOP. Higher placebo responses on N2 and P2 amplitudes were both related to higher placebo analgesic magnitude in pain unpleasantness. In conclusion, increased FOP was found to reduce subjective and electrophysiological placebo analgesic responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The validation of visual analogue scales as ratio scale measures for chronic and experimental pain
Price, D. D., McGrath, P. A., Rafii, A., & Buckingham, B. (1983) · Pain · doi:10.1016/0304-3959(83)90126-4 · Cited by 3,921
Rethinking feelings: an fMRI study of the cognitive regulation of emotion
Ochsner, K. N., Bunge, S. A., Gross, J. J., & Gabrieli, J. D. E. (2002) · Journal of Cognitive Neuroscience · doi:10.1162/089892902760807212 · Cited by 2,520 · cited 1×
“The N2 and P2 components have consistently been related to anterior cingulate cortex (ACC) activity [19], which is involved in placebo analgesia [48,62,65], and which is important for pain modulation by emotional processes [45,47,49,66].”
BackgroundPsychological and neural mechanisms of the affective dimension of pain
Price, D. D. (2000) · Science · doi:10.1126/science.288.5472.1769 · Cited by 2,092 · cited 1×
“The N2 and P2 components have consistently been related to anterior cingulate cortex (ACC) activity [19], which is involved in placebo analgesia [48,62,65], and which is important for pain modulation by emotional processes [45,47,49,66].”
BackgroundPlacebo and Opioid Analgesia-- Imaging a Shared Neuronal Network
Petrovic, P., Kalso, E., Petersson, K. M., & Ingvar, M. (2002) · Science · doi:10.1126/science.1067176 · Cited by 1,488 · cited 1×
“The N2 and P2 components have consistently been related to anterior cingulate cortex (ACC) activity [19], which is involved in placebo analgesia [48,62,65], and which is important for pain modulation by emotional processes [45,47,49,66].”
BackgroundTHE MECHANISM OF PLACEBO ANALGESIA
Levine, J., Gordon, N., & Fields, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92762-9 · Cited by 1,094
State-dependent opioid control of pain
Fields, H. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1431 · Cited by 946 · cited 2×
“It also means that both systems can be activated at the same time to varying degrees, and by implication, that the total inhibitory effect of opioids depends on the level of facilitatory influence [14].”
BackgroundPlacebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors
Zubieta, J.-K., Bueller, J. A., Jackson, L. R., Scott, D. J., Xu, Y., Koeppe, R. A., Nichols, T. E., & Stohler, C. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0439-05.2005 · Cited by 779 · cited 2×
“The N2 and P2 components have consistently been related to anterior cingulate cortex (ACC) activity [19], which is involved in placebo analgesia [48,62,65], and which is important for pain modulation by emotional processes [45,47,49,66].”
BackgroundBrain generators of laser-evoked potentials: from dipoles to functional significance
Garcia-Larrea, L., Frot, M., & Valeriani, M. (2003) · Neurophysiologie Clinique/Clinical Neurophysiology · doi:10.1016/j.neucli.2003.10.008 · Cited by 541 · cited 3×
“The N2 and P2 components have consistently been related to anterior cingulate cortex (ACC) activity [19], which is involved in placebo analgesia [48,62,65], and which is important for pain modulation by emotional processes [45,47,49,66].”
BackgroundIndividual differences in reward responding explain placebo-induced expectations and effects
Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A., & Zubieta, J.-K. (2007) · Neuron · doi:10.1016/j.neuron.2007.06.028 · Cited by 466 · cited 2×
“Accordingly, although placebos have appetitive motivational power [55,56] in our study, this was only sufficient to cause pain inhibition for those lower in FOP and not for those higher in FOP.”
BackgroundThe biochemical and neuroendocrine bases of the hyperalgesic nocebo effect
Benedetti, F., Amanzio, M., Vighetti, S., & Asteggiano, G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2947-06.2006 · Cited by 419 · cited 1×
“Additionally, placebo analgesia studies have shown that the blockade of CCK, a peptide with antiopioid qualities [15] triggered by fear and anxiety [7], increases placebo analgesic magnitude [5,6].”
Background
Cited by
The placebo response in medicine: minimize, maximize or personalize?
Enck, P., Bingel, U., Schedlowski, M., & Rief, W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3923 · Cited by 671
Physiologic Effects of Dry Needling
Cagnie, B., Dewitte, V., Barbe, T., Timmermans, F., Delrue, N., & Meeus, M. (2013) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0348-5 · Cited by 336
Schedlowski, M., Enck, P., Rief, W., & Bingel, U. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009423 · Cited by 323
“These include anxiety and fear (Flaten et al., 2011; Lyby et al., 2011), hypnotic suggestibility (De Pascalis et al., 2002), locus of control and self-efficacy (Horing et al., 2015), hostility (Peciña et al., 2013a), coping abilities (Schneider et al., 2006), dispositional optimism (Morton et al.,…”
BackgroundPlacebo analgesia: Psychological and neurobiological mechanisms
Colloca, L., Klinger, R., Flor, H., & Bingel, U. (2013) · Pain · doi:10.1016/j.pain.2013.02.002 · Cited by 263
“Moreover, neuroimaging studies indicate that the reduced pain ratings during placebo analgesia are paralleled by decreased activity in the classical pain-processing areas including the thalamus, insula, and the somatosensory cortex [6,11,20,24, 25,30,31].”
BackgroundThe placebo effect: advances from different methodological approaches
Meissner, K., Bingel, U., Colloca, L., Wager, T. D., Watson, A., & Flaten, M. A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4099-11.2011 · Cited by 178
“Karin Meissner,1,2* Ulrike Bingel,3* Luana Colloca,4,5* Tor D. Wager,6* Alison Watson,7* and Magne Arve Flaten8* 1Institute of Medical Psychology, Ludwig-Maximilians-University of Munich, D-80336 Munich, Germany, 2Institute of General Practice, Technical”
BackgroundSelf-citation
Metadata
- Authors
- Lyby, P. S., Aslaksen, P. M., & Flaten, M. A.
- Venue
- Pain
- Published
- 2011-10
- Volume
- 152
- Issue
- 10
- Pages
- 2405-2412
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W1992458659
- Cited by
- 103
- References
- 21
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Variability in placebo analgesia and the role of fear of pain—an ERP study. https://app.cochat.ai/papers/10.1016/j.pain.2011.07.010
- The paper
- Lyby, P. S., Aslaksen, P. M., & Flaten, M. A. (2011). Variability in placebo analgesia and the role of fear of pain—an ERP study. Pain. https://doi.org/10.1016/j.pain.2011.07.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.